$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
4 Growth Stocks Under $10 to Buy for 2022
04:20pm, Wednesday, 29'th Dec 2021 Zacks Investment Research
Growth stocks tend to perform well when the economy starts to pick up. Nissan Motor (NSANY), Arko Corp. (ARKO), Arcos Dorados (ARCO) and Cerus (CERS) look well-poised to grow.
4 Growth Stocks Under $10 to Buy for 2022
01:04pm, Wednesday, 29'th Dec 2021
Growth stocks tend to perform well when the economy starts to pick up. Nissan Motor (NSANY), Arko Corp. (ARKO), Arcos Dorados (ARCO) and Cerus (CERS) look well-poised to grow.
How Much Upside is Left in Cerus (CERS)? Wall Street Analysts Think 44%
03:00pm, Tuesday, 28'th Dec 2021 Zacks Investment Research
The consensus price target hints at a 43.9% upside potential for Cerus (CERS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate re
How Much Upside is Left in Cerus (CERS)? Wall Street Analysts Think 44%
11:30am, Tuesday, 28'th Dec 2021
The consensus price target hints at a 43.9% upside potential for Cerus (CERS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate re
Why Buying The Cerus Corporation (NASDAQ: CERS) Stock Today Might Make Sense
02:30pm, Wednesday, 22'nd Dec 2021 Stocks Register
Cerus Corporation (NASDAQ:CERS) traded at $6.81 at close of the session on Tuesday, 12/21/21, made an upward move of 2.87% on its previous days price. Looking at the stock we see that its previous close was $6.62 and the beta (5Y monthly) reads 1.23 with the days price range being $6.66 $6.825. In terms Why Buying The Cerus Corporation (NASDAQ: CERS) Stock Today Might Make Sense Read More »
3 Beaten-Down Medical Product Stocks to Buy on a Turnaround in 2022
01:06pm, Tuesday, 21'st Dec 2021 Zacks Investment Research
Here are some medical product stocks from the MedTech sector - Quidel (QDEL), Cerus (CERS) and NextGen Healthcare (NXGN) - which might be witnessing a turnaround in 2022 and be solid investment option
3 Beaten-Down Medical Product Stocks to Buy on a Turnaround in 2022
09:12am, Tuesday, 21'st Dec 2021
Here are some medical product stocks from the MedTech sector - Quidel (QDEL), Cerus (CERS) and NextGen Healthcare (NXGN) - which might be witnessing a turnaround in 2022 and be solid investment option
What Analysts Were Expecting After Cerus Corporation (NASDAQ: CERS) rose 7.90%
05:00pm, Saturday, 18'th Dec 2021 Stocks Register
Cerus Corporation (NASDAQ:CERS) shares, rose in value on Friday, 12/17/21, with the stock price up by 7.90% to the previous days close as strong demand from buyers drove the stock to $6.69. Actively observing the price movement in the last trading, the stock closed the session at $6.20, falling within a range of $6.12 and What Analysts Were Expecting After Cerus Corporation (NASDAQ: CERS) rose 7.90% Read More »
Cerus (NASDAQ:CERS) Rating Increased to Buy at Zacks Investment Research
08:58am, Sunday, 28'th Nov 2021 Dakota Financial News
Zacks Investment Research upgraded shares of Cerus (NASDAQ:CERS) from a hold rating to a buy rating in a research note issued to investors on Wednesday, Zacks.com reports. They currently have $8.00 price objective on the biotechnology companys stock. According to Zacks, Cerus Corporation is developing medical products based on a platform technology that prevents nucleic []
Wall Street Analysts Think Cerus (CERS) Could Surge 35%: Read This Before Placing a Bet
03:00pm, Wednesday, 24'th Nov 2021 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 35.4% in Cerus (CERS). While the effectiveness of this highly sought-after metric is questionable, the positive
Artificial Blood Market Shows Impressive Rise in the Industry Growth Rate, Players Baxter International, Cerus Corporation,,
07:03am, Wednesday, 24'th Nov 2021 OpenPR
*** The operating environment for global organizations is increasingly getting complex. This has left organizations playing catch-up with constantly emerging new business strategies. There is a growing demand for the inclusion of best-consulting services in sync with the organizations business
Cerus Co. (NASDAQ:CERS) Position Increased by Credit Suisse AG
09:44am, Tuesday, 23'rd Nov 2021 Dakota Financial News
Credit Suisse AG raised its holdings in shares of Cerus Co. (NASDAQ:CERS) by 20.0% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 179,991 shares of the biotechnology companys stock after buying an additional 29,944 shares during the period. Credit Suisse AG owned about 0.10% []
Cerus Corporation to Participate in Stephens Annual Investment Conference
01:00pm, Friday, 19'th Nov 2021 Business Wire
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced that Kevin D. Green, Cerus’ chief financial officer, is scheduled to participate in the Stephens Annual Investment Conference in Nashville, Tenn., on Friday, December 3, 2021 at 2:00 p.m. ET. A live webcast of the event will be available on the Investor Relations page of the Cerus web site at http://www.cerus.com/ir. A replay will be available for approximately two weeks following the completion of the event. ABO
Bouvel Investment Partners LLC Takes Position in Cerus Co. (NASDAQ:CERS)
06:22pm, Tuesday, 16'th Nov 2021 Transcript Daily
Bouvel Investment Partners LLC acquired a new stake in shares of Cerus Co. (NASDAQ:CERS) in the third quarter, Holdings Channel.com reports. The fund acquired 214,457 shares of the biotechnology company’s stock, valued at approximately $1,306,000. Several other large investors also recently made changes to their positions in CERS. Miracle Mile Advisors LLC acquired a new […]
Silverarc Capital Management, Llc Buys Fulcrum Therapeutics Inc, Cogent Biosciences Inc, Cerus ...
03:38pm, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: COGT , CERS , NXTC , IMTX , CLDX , MCRB , FULC , ARVN , LPTX , ERAS , CYTK , LHDX , DRNA , RNLX , KDNY , MGNX , VSTM , TCRR , ALDX , CGEM ,
Sign In
Buy CERS